Altimmune Inc reports a Return on Equity (ROE) of -32.07%.

What is ALT's dividend yield?

Altimmune Inc offers a dividend yield of 0.00%.

What is ALT's Quality Score?

Our AI rates ALT's overall financial quality at 38 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy ALT?

Our AI Timing Score for ALT is 26 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does ALT belong to?

Altimmune Inc is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange

Altimmune Inc (ALT) Stock Price, Quality Score & AI Analysis

Stock Check Daily update data at 8:30 AM
(Price: 2026-07-31 | FS: 2026-03-31)

ALT AI Analysis Summary

Our AI summary for ALT: Altimmune Inc (NASDAQ), Healthcare >> Biotechnology sector. The stock currently trades at a P/E of 0.00, ROE of -32.07%, a dividend yield of 0.00%. Its financial Quality Score stands at 38/100 — fundamentals below the market average. The AI Timing Score is 26/100 — most technical signals do not support an entry at this point. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.

ALT

Altimmune Inc

US:NASDAQ STOCK Healthcare >> Biotechnology News 89

USD 2.84

-0.14 (-4.70%) Day Change

Watchlist Portfolio Compare Chart

0.12

D/E

-32.1%

ROE

-27.1%

ROA

0.00%

Div Yield

ALTIMMUNE INC
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 2.84 Price -0.14 (-4.70%) Day Change	NEWS SCORE: 89

ALT, the overall quality is not good ( Quality = 38) and the timing to buy is ...(Sign In to See)...

Loading chart...

38 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: ROE is relatively low.
ROA is relatively low.
Acceleration of ROE growth rate is below our criteria.
Historical ROE is relatively low
ROA is too relatively low compare to ROE
Acceleration of ROA growth rate is below our criteria.
Net profit margin is relatively low.
Historical net profit margin is relatively low.

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Momentum indicators aligned on the daily timeframe

Unlock timing signals and detailed reasons

In details, quality factors are not good , financial health is not good , and ability to make profit is not quite good , ...

Quality Factors

44%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	89
Magic Formula Rank by ROA	560
Magic Formula Rank by ROE	560
Magic Formula Rank by ROIC	599
Price	2.84
PBV / Sector	2.04 / 5.20
Earning Per Share	-0.45

PE / Sector	N/A / 19.97
PEG or PE/Growth / Sector	N/A / 1.22
Average 1M Daily Value	12.03 M GREAT
Average 1W Daily Value	22.73 M GREAT

Timing Factors

28%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Financial Health

45%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

Ability to Make Profit

52%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	-253,002.78 / 98.71
NPM Average (%) / Sector	-167,868.60 / -1,721.76
NPM Change Average (%) / Sector	508.88 / 5,211.62 GREAT
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	-27.14 / 27.02
ROA Average (%) / Sector	-41.95 / -368.17
ROA Change Average (%) / Sector	-0.64 / 5,404.12
ROE (%) / Sector	-32.07 / 3.47
ROE Average (%) / Sector	-47.90 / 6.51
ROE Change Average (%) / Sector	0.34 / 2,128.13
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

Return to Investors

Dividend (%) / Sector	N/A / 0.04
Dividend Average (%) / Sector	N/A / 17.04
Dividend Change Average (%) / Sector	N/A / -1.75

Registration Details

Analyze Date	2026-08-01 07:59:27
Symbol	ALT
Name	ALTIMMUNE INC
Sector	Healthcare >> Biotechnology
Market	NASDAQ
Listed Shares	194.47 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	579.53 / 9,903.94

News, Concensus, ...

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 910 Clopper Road, Gaithersburg, MD, United States, 20878

Phone: 240 654 1450

Website: https://altimmune.com

Employees: 57

Sector: Healthcare >> Biotechnology

Description: Altimmune, Inc., a late clinical stage biopharmaceutical company, focuses on developing novel therapies for serious liver diseases. Its lead product candidate is pemvidutide, a GLP-1/glucagon dual receptor agonist, which is in Phase 3 clinical trial for the treatment of metabolic dysfunction-associated steatohepatitis, alcohol use disorder, and alcohol-associated liver disease. The company was founded in 1997 and is headquartered in Gaithersburg, Maryland.